Pure Global

Sugar Selection Blood Glucose Test System - Taiwan Registration 1719054508ac6237bb6f3f99e4629d89

Access comprehensive regulatory information for Sugar Selection Blood Glucose Test System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1719054508ac6237bb6f3f99e4629d89 and manufactured by Qiaolian Technology Co., Ltd. Nankan Factory. The authorized representative in Taiwan is BIOCARE CORPORATION.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
1719054508ac6237bb6f3f99e4629d89
Registration Details
Taiwan FDA Registration: 1719054508ac6237bb6f3f99e4629d89
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Sugar Selection Blood Glucose Test System
TW: ็ณ–ๆ‚ ็ฒพ้ธ่ก€็ณ–ๆธฌ่ฉฆ็ณป็ตฑ
Risk Class 2

Registration Details

1719054508ac6237bb6f3f99e4629d89

DHY00500359400

Company Information

Taiwan, Province of China

Product Details

This product can detect the blood glucose value of fingertips, palms, forearms or upper arm microvessels in diabetic patients, and is not suitable for newborns.

A Clinical chemistry and clinical toxicology

A.1345 Glucose Test System

Domestic

Dates and Status

Mar 09, 2012

Mar 09, 2027